Financials

  • Market Capitalization 375.39 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2
Rapporto prezzo/fatturato
11.96

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3145
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.74 USD+0.85%0.00%+7.73%+47.66%379.33 M USD
3147
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.10 USD-0.08%-8.07%+14.51%+98.79%380.93 M USD
3179
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.63 USD+0.22%-7.40%-1.91%+11.30%363.56 M USD
3207
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.83 USD-0.34%-9.05%-0.85%+5.42%350.59 M USD

Notizie